- Home
- ARE vs SNN Comparison
ARE vs SNN Comparison
Compare ARE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARE | SNN |
|---|---|---|
| Founded | 1994 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 14.0B |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ARE | SNN |
|---|---|---|
| Price | $45.56 | $33.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $69.38 | $32.83 |
| AVG Volume (30 Days) | ★ 2.9M | 476.9K |
| Earning Date | 01-26-2026 | 03-02-2026 |
| Dividend Yield | ★ 10.29% | 2.19% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | N/A | ★ 0.56 |
| Revenue | $3,058,395,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | N/A | $7.78 |
| Revenue Next Year | N/A | $5.13 |
| P/E Ratio | ★ N/A | $29.10 |
| Revenue Growth | N/A | ★ 5.35 |
| 52 Week Low | $45.47 | $23.69 |
| 52 Week High | $107.19 | $38.79 |
Technical Indicators
Market Signals| Indicator | ARE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 25.29 | 48.01 |
| Support Level | $52.39 | $32.68 |
| Resistance Level | $54.17 | $33.56 |
| Average True Range (ATR) | 1.84 | 0.41 |
| MACD | 0.30 | 0.14 |
| Stochastic Oscillator | 0.06 | 78.51 |
Price Performance
Historical ComparisonAbout ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.